Neuropeptide blend

Cerebrolysin

A neurotrophic blend used for brain recovery and cognition.

Clinical evidence

Overview

Cerebrolysin is a mixture of neuropeptides derived from purified pig brain protein. It is approved and widely used as a prescription medicine in Europe, Asia, and other regions for stroke rehabilitation and cognitive decline. In the United States it is not FDA-approved but is available through compounding and research channels. How it works: The neuropeptides in Cerebrolysin have growth-factor-like effects - they support the survival of existing neurons, promote repair after injury, and may support formation of new neuronal connections. The mechanism is broadly described as neurotrophic and neuroprotective. Who tends to use it: People with strong cognition goals, particularly those recovering from neurological events or dealing with significant age-related cognitive concerns. It also carries a minor supportive rating for longevity, reflecting its cellular-maintenance effects. How it is taken: Cerebrolysin is given by intramuscular (IM) or intravenous (IV) injection. It is not taken orally - it must be injected to remain intact and reach the brain. Administration happens as supervised courses of 10-20 days, during which it is given daily. This course structure is standard and reflects how the drug is used in its approved markets. Dosing within each course is per protocol. What to expect: The evidence base for Cerebrolysin includes genuine clinical trials, primarily in stroke and dementia populations. Effects in healthy, cognitively intact users are less studied. Because it is given as a structured course under supervision, you will have clinical check-ins throughout. Safety: The main practical note is that Cerebrolysin is administered as supervised courses, not self-injected at home on a flexible schedule. There are no excludeIf flags in the record. Your licensed provider in the PepDepo network will determine whether Cerebrolysin is appropriate for your goals and set the course structure and dose at consult.

At a glance

Route

IM or IV

Dose

Per protocol (course-based)

Frequency

Daily for a course

Timing

Per protocol

Cycle

10-20 day courses

Combining

Stacks well with: Semax

Safety

Administered as supervised courses.

Regulatory: Approved in many countries; not FDA-approved.

Questions

How is Cerebrolysin given?⌄

By intramuscular (IM) or intravenous (IV) injection. It is administered as a daily course of 10-20 days under clinical supervision - not as a self-injected at-home peptide.

Why does it have to be injected?⌄

As a peptide blend, Cerebrolysin breaks down in the digestive tract before reaching the bloodstream. Injection is required to preserve its activity.

What goals is it used for?⌄

Its primary rating is cognition. It also has a minor supportive rating for longevity, reflecting its neuroprotective mechanisms.

Is there real clinical evidence behind it?⌄

Yes - Cerebrolysin is classified as 'clinical' evidence in the data, the highest tier used in the catalog. It has genuine clinical trial data, mainly in stroke rehabilitation and dementia, which is why it is approved as a prescription drug in many countries.

Is it approved in the US?⌄

Not by the FDA. It is approved in many other countries. In the US it is available through compounding and research pathways, which your clinician will explain.

Are there any contraindications?⌄

The record lists no excludeIf flags for Cerebrolysin. That said, because it requires supervised injection courses, full clinical review is always part of the process.

Can it be combined with other nootropics?⌄

Semax is the listed synergy candidate. Whether combining makes sense for you is something your clinician will evaluate at consult.

Want a personalized protocol?

Exact dosing is set with a licensed provider in the PepDepo network. This page is education, not a prescription.

Book a consult

Education only, not medical advice. Peptides discussed are for informational purposes and many are not FDA-approved. Eligibility, prescribing, compounding, and dispensing are handled by appropriately licensed entities. Exact protocols and dosing are set with a licensed provider in the PepDepo network at consult. Content is pending clinical review.